Assessment of the relationship between endocan and obstructive sleep apnea severity
Open Access
- 1 January 2020
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 16 (6) , 1346-1352
Abstract
Introduction Obstructive sleep apnea (OSA) and endothelial dysfunction are associated with cardiovascular risk factors and the development of atherosclerosis. Endocan is a marker of endothelial dysfunction, while obstructive sleep apnea is one of the causes of endothelial dysfunction. In this...Keywords
This publication has 39 references indexed in Scilit:
- Sleep apnea in the elderly: A specific entity?Sleep Medicine Reviews, 2007
- Endocan, a new endothelial marker in human sepsis*Critical Care Medicine, 2006
- Obstructive Sleep Apnea as a Risk Factor for Stroke and DeathNew England Journal of Medicine, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal AntibodiesJournal of Vascular Research, 2000
- ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by CytokinesJournal of Biological Chemistry, 1996
- Microalbuminuria and endothelial dysfunction in essential hypertensionThe Lancet, 1994
- Snoring and Cardiovascular Risk FactorsAnnals of Medicine, 1994